维普期刊资源整合服务平台（V6.5）

213篇 您的检索式：作者名="ROSENFELD PJ"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration显示文摘	ROSENFELD PJ SCHWARTZ SD BLUMENKRANZ MS	2005	Ophthalmology2005，112，6：	1
2	Optical coherence tomography findings after an intravitreal injection of bevaeizumab (Avastin) for macular edema from central retinal vein occlusion 显示文摘	Rosenfeld PJ Fung AE Puliafito CA	2005	Ophthalmic Surg Lasers Imag2005，36，：	1
3	Predicted biological activityof intravitreal VEGF Trap显示文摘	STEWART MWf ROSENFELD PJ	2008	Br J Ophthalmol2008，92，5：	1
4	RhuFab V2 (anti-VEGF antibody fragment) in neovascular AMD: safety, tolerability, and efficacy of multiple, escalating does intravitreal injection 显示文摘	ROSENFELD PJ VILLATE N FEUER WJ	2003	Invest Ophthalmol Vis Sci2003，44，3：	1
5	Endovascular management of vein of Galen aneurismal malformations presenting in the neonatal period显示文摘	Mitchell PJ Rosenfeld JV Dargaville P	2001	AJNR2001，22，7：	1
6	Ranibizumab for neovascular age-related macular degeneration显示文摘	Rosenfeld PJ Brown DM Heier JS	2006	N Engl J Med2006，355，14：	1
7	The international intravitreal bevacizumab safety survey: Using the internet to assess drug safety worldwide 显示文摘	Fung AE Rosenfeld PJ Reichel E	2006	Br J Ophthalmol2006，90，11：	1
8	Ranibizumab for neovascular age-related macular degeneration显示文摘	Rosenfeld PJ	2006	N Engl J Med2006，355，14：	1
9	Optical coherence tomography findings after an intravitreal injection of bevacizumab(Avastin)for neovascular age related macular degeneration显示文摘	Rosenfeld PJ Moshfeghi AA Puliafito CA	2005	Ophthalmic Surg Lasers Imaging2005，36，4：	1
10	Intravitreal triamcinolone acetonid for idiopathic cystoid macular edema显示文摘	Scott IU Flynn HW Jr Rosenfeld PJ	2003	Am J Ophthalmol2003，136，4：	1
11	Optical coherence tomography findings after an intravitreal injection ofbevacizumab(Avastin) for macular edema from central retinal vein occlusion显示文摘	Rosenfeld PJ lung AE Puliafito	2005	Ophthalmic SurgLasers zmaging2005，36，4：	1
12	Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration显示文摘	Rosenfeld PJ Schwartz SD Blumenkranz MS	2005	Ophthalmology2005，112，6：	1
13	Ranibizumab for neovascular age-related macular degeneration 显示文摘	ROSENFELD PJ BROWN DM HEIER JS	2006	N Engl J Med2006，355，14：	1
14	Antivascular endothelial growth factor therapy for neovascular age -related macular degeneration显示文摘	Ciulla TA Rosenfeld PJ	2009	Curr Opin Ophthalmo12009，20，3：	1
15	Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration显示文摘	Ciulla TA Rosenfeld PJ		0，，：	1
16	Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization显示文摘	Tabandeh H Flynn HW Scott IU Lewis ML Rosenfeld PJ Rodriguez F	1999	Ophthalmology1999，106，：	1
17	Ranibizumab for neovas- cular age-related macular degeneration 显示文摘	Rosenfeld PJ Brown DM Heier JS	2006	N Engl J Med2006，355，14：	1
18	Ranibizumab for neovas- cular age-related macular degeneration显示文摘	Rosenfeld PJ Brown DM Heier JS	2006	N Engl J Med2006，355，14：	1
19	Ranibiztumab: Phase Ⅲ clinical trial results显示文摘	Rosenfeld PJ Rich RM Lalwaul GA	2006	Ophthalmol Clin North Am2006，19，3：	1
20	Systemic bevacizumab(Avastin)therapy for neovascular age-related macular degeneration: twelve week results of an uncontrolled open-label clinical study显示文摘	Michels S Rosenfeld PJ Puliafito CA	2005	Ophthalmology2005，112，：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示